Purpose: The most important challenges in photodynamic therapy (PDT) are related to the limited penetration of light and the low uptake of photosensitizers. In radiotherapy, they are correlated to radiation damage of normal tissues. Therefore, a targeted radio and photosensitizer can reduce the limitations of the mentioned methods. In this study, photosensitizing and radio-sensitizing effects of 5-aminolevulinic acid (5ALA)-conjugated GNPs were investigated.

Materials And Methods: First, cell toxicities of 5ALA, GNPs and a conjugate were assessed on Mel-Rm cell line. Then, the radio sensitizing effect of every agent was studied. Different experiments were designed in four separate groups, each group containing six subgroups receiving different radiation doses by using a superficial X-ray tube. Furthermore, the photosensitizing efficacy of the agents was evaluated after cells were irradiated by a He-Ne laser at four light doses in separate groups.

Results: With regards to radio sensitivity assessments, there was no significant difference between different irradiation doses. The investigation on photosensitivity of 5ALA and a conjugate showed significant differences between the control (without illumination) and groups that received PDT in the presence of 5ALA and conjugate, wherein ED were estimated at 136.2 J/cm and 56.2 J/cm, respectively. With regards to PDT experiments, the conjugate induces cell death more than twice in comparison with 5ALA.

Conclusion: The conjugate does not cause any enhancement of radiation efficiency on MeL-Rm cell line. With regards to PDT, we found that the conjugate induced cell death at twice the rate when compared with 5ALA alone. Therefore, the conjugate can be an appropriate delivery agent for 5ALA and may also enhance the destruction of tumor cells. Finally, comparing the two types of treatment shows that PDT is a more efficient treatment for this cell line.

Download full-text PDF

Source
http://dx.doi.org/10.3109/21691401.2016.1167697DOI Listing

Publication Analysis

Top Keywords

5ala conjugate
12
photodynamic therapy
8
5-aminolevulinic acid
8
mel-rm cell
8
cell death
8
cell
7
conjugate
7
pdt
5
5ala
5
comparative study
4

Similar Publications

Glioblastoma (GBM) poses significant challenges regarding complete tumor removal due to its heterogeneity and invasiveness, emphasizing the need for effective therapeutic options. In the last two decades, fluorescence-guided surgery (FGS), employing fluorophores such as 5-aminolevulinic acid (5-ALA) to enhance tumor delineation, has gained attraction among neurosurgeons. However, some low-grade tumors do not show any accumulation of the tracers, and the lack of patient stratification represents an important limitation.

View Article and Find Full Text PDF

Objective: Glioblastoma multiforme is a highly aggressive form of brain cancer, and early diagnosis plays a pivotal role in improving patient survival rates. In this regard, molecular magnetic resonance imaging has emerged as a promising imaging modality due to its exceptional sensitivity to minute tissue changes and the ability to penetrate deep into the brain. This study aimed to assess the efficacy of a novel contrast agent in detecting gliomas during MRI scans.

View Article and Find Full Text PDF

Enhancement of the effect of novel targeted 5-aminolevulinic acid conjugated bismuth oxide nanoparticles-based photodynamic therapy by simultaneous radiotherapy on KB cells.

Photodiagnosis Photodyn Ther

April 2024

Department of Medical Physics, School of Medicine, Kermanshah University of Medical Sciences, Sorkheh-Lizhe Blvd, Kermanshah, P.O.Box:1568, Iran. Electronic address:

Background: Selective accumulation of photosensitizers into cancerous cells is one of the most important factors affecting photodynamic therapy (PDT) efficacy. 5-aminolevulinic acid (5-ALA) is the precursor of a strong photosensitizer, protoporphyrin-IX; but it has poor permeability into the cells. Folate receptors are overexpressed on the surface of many tumor cells.

View Article and Find Full Text PDF

Herein, the impact of surface charge tailored of gold nanorods (GNRs) on breast cancer cells (MCF-7 and MDA-MB-231) upon conjugation with triphenylphosphonium (TPP) for improved photodynamic therapy (PDT) targeting mitochondria was studied. The salient features of the study are as follows: (i) positive (CTAB@GNRs) and negative (PSS-CTAB@GNRs) surface-charged gold nanorods were developed and characterized; (ii) the mitochondrial targeting efficiency of gold nanorods was improved by conjugating TPP molecules; (iii) the conjugated nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) were evaluated for PDT in the presence of photosensitizer (PS), 5-aminolevulinic acid (5-ALA) in breast cancer cells; (iv) both nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) induce apoptosis, damage DNA, generate reactive oxygen species, and decrease mitochondrial membrane potential upon 5-ALA-based PDT; and (v) 5-ALA-PDT of two nanoprobes (TPP-CTAB@GNRs and TPP-PSS-CTAB@GNRs) impact cell signaling (PI3K/AKT) pathway by upregulating proapoptotic genes and proteins. Based on the results, we confirm that the positively charged (rapid) nanoprobes are more advantageous than their negatively (slow) charged nanoprobes.

View Article and Find Full Text PDF

Triphenylphosphonium conjugated gold nanotriangles impact Pi3K/AKT pathway in breast cancer cells: a photodynamic therapy approach.

Sci Rep

February 2023

Food Chemistry and Molecular Cancer Biology Lab, Department of Animal Health and Management, Alagappa University, Karaikudi, Tamil Nadu, 630 003, India.

Although gold nanoparticles based photodynamic therapy (PDT) were reported to improve efficacy and specificity, the impact of surface charge in targeting cancer is still a challenge. Herein, we report gold nanotriangles (AuNTs) tuned with anionic and cationic surface charge conjugating triphenylphosphonium (TPP) targeting breast cancer cells with 5-aminoleuvinic acid (5-ALA) based PDT, in vitro. Optimized surface charge of AuNTs with and without TPP kill breast cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!